<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136086">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01796080</url>
  </required_header>
  <id_info>
    <org_study_id>PAF_V1.1 (05.07.2012)</org_study_id>
    <nct_id>NCT01796080</nct_id>
  </id_info>
  <brief_title>The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation</brief_title>
  <official_title>The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomised controlled cross-over study we will investigate whether intrathoracic
      pressure changes induced by simulated obstructive apnoea and hypopnoea trigger premature
      supraventricular and ventricular contractions as well as atrial fibrillation in patients
      with paroxysmal atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Number of subjects with premature myocardial contractions and/or atrial fibrillation</measure>
    <time_frame>20 seconds</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ECG-derived myocardial de- and repolarization times</measure>
    <time_frame>20 seconds</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Patients With Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Mueller manoeuvre</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mueller manoeuvre lasting for 20 seconds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inspiratory threshold</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One continuous inspiration through an inspiratory threshold load for 20 seconds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expiratory apnoea</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Expiratory apnoea (without respiratory effort) lasting for 20 seconds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Steady state normal breathing</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Steady state normal breathing for 20 seconds</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mueller manoeuvre</intervention_name>
    <arm_group_label>Mueller manoeuvre</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspiratory threshold</intervention_name>
    <arm_group_label>Inspiratory threshold</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Expiratory apnoea</intervention_name>
    <arm_group_label>Expiratory apnoea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Steady state normal breathing</intervention_name>
    <arm_group_label>Steady state normal breathing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age 18-75 years

          -  History of ECG-documented paroxysmal atrial fibrillation within the last 12 months
             and currently in sinus rhythm

          -  Informed consent

        Exclusion criteria:

          -  Mental or physical disability precluding informed consent or compliance with the
             protocol

          -  Amiodarone or Dronedarone medication

          -  Previous radiofrequency ablation for atrial fibrillation

          -  Severe structural heart disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malcolm Kohler, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Pneumology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Pneumology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 20, 2013</lastchanged_date>
  <firstreceived_date>February 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
